Krishna Institute of Medical Sciences Limited KIMSshare price and chart
Krishna Institute of Medical Sciences closed at ₹767.80 on 19 November 2026, up 1.16% on the day. The 52-week range is ₹575.80 to ₹858.00.
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on KIMS
Real prices, every charge counted. Pick one or write your own.Krishna Institute of Medical Sciences runs hospitals, 96.8% of its turnover, offering services across 40 specialties including cardiac sciences, oncology, neurosciences, orthopaedics, organ transplantation, renal sciences and mother and child care, for insured and uninsured patients in three states.
Healthcare Services
Multi-specialty hospital care
Insured and uninsured patients
Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 19 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Against its sectorWhere this company ranks among similar companies on each measure.
Hospital · 28 peers · mediansWhat the numbers sayShort plain statements about this company's latest figures.
Written by fixed rulesLatest quarterIn the quarter to September 2026 (results filed 4 Nov 2026), sales rose 39.9% from a year earlier to ₹1,344 cr and profit rose 3.6% to ₹74.6 cr.
- Sales grew 3 years running (₹2,198 cr in FY23 to ₹3,905 cr in FY26).
- Cash from operations was at least the reported profit in each of FY24, FY25, FY26.
- Operating margin fell from 27.5% in FY23 to 20.5% in FY26.
- Debt to equity rose 3 years running (0.35 to 1.27).
- Promoters had pledged 11.7% of their shares at the end of September 2026, 3.83% of all shares.
- Promoter holding fell 6.2 points over 7 quarters (38.82% to 32.66%).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Share price reaction to resultsWhat the share price did around each recent quarterly result.
Over the last 18 results, the share rose on 11 and fell on 7, and moved by 3% or more on 3.
Q2 FY27: results filed 4 Nov 2026. The share went from its close on 3 Nov 2026 to its close on 5 Nov 2026 +0.08%.
What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.
Price only, before dividendsHeld for 5 years this compounded at +25.0% a year. The last twelve months were up +15.7%. Price only, before dividends.
Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Who owns itEach line is that holder's share of all shares over the last 8 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.
The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsKey ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Hospital. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Revenue and profit, year by yearSales and net profit by financial year or by quarter.
Sales and net profitWhere every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.
FY26In FY26, of every ₹100 of sales it kept ₹6.2 as profit. Other income added ₹0.7.
How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.
Compounded a yearCash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
Where the cash wentIn FY26 cash fell by ₹1 Cr, after ₹1,428 Cr spent on plant and equipment.
Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales growthSales in this financial year against the previous one. | · | 13.7% | 21.5% | 28.7% |
| Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax. | 27.5% | 25.6% | 25.8% | 20.5% |
| Net marginOf every ₹100 of sales in the year, how much was left as profit after everything. | 16.6% | 13.5% | 13.7% | 6.2% |
| ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | 18.9% | 16.7% | 18.4% | 9.7% |
| ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders. | 19.7% | 16.7% | 15.4% | 9.9% |
| Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | 0.35x | 0.65x | 1.06x | 1.27x |
| Interest coverHow many times the company's profit before interest could pay its interest bill. | 16.9x | 10.8x | 7.2x | 2.6x |
Each row against this company's own usual level: green better, red worse, grey close to it.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Hospital| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP Apollo Hospitals Enterprise Limited | 1.26 L cr | 56.0x | 11.8x | 21.5% | 20.7% | 0.50 | 8.4% | +20.8% | 0.23% |
| MAXHEALTH Max Healthcare Institute Limited | 1.01 L cr | 73.3x | 8.9x | 14.3% | 14.4% | 0.33 | 15.1% | +20.3% | 0.19% |
| MANIPALHOS Manipal Health Enterprises Limited | 91,609 cr | - | 5.5x | - | - | 0.34 | - | - | 0.00% |
| ASTERDM Aster DM Quality Care Limited | 64,443 cr | 102.1x | 8.3x | 10.1% | 14.8% | 0.43 | 8.7% | +136.3% | 0.41% |
| FORTIS Fortis Healthcare Limited | 61,140 cr | 58.9x | 5.8x | 11.0% | 13.5% | 0.29 | 10.7% | +17.3% | 0.12% |
| MEDANTA Global Health Limited | 39,747 cr | 64.2x | 9.2x | 15.0% | 17.9% | 0.16 | 12.1% | +33.6% | 0.03% |
| NH Narayana Hrudayalaya Ltd. | 38,279 cr | 44.3x | 7.7x | 19.7% | 16.0% | 0.99 | 8.4% | +73.0% | 0.24% |
| KIMS Krishna Institute of Medical Sciences Limited | 32,248 cr | 147.1x | 8.2x | 9.7% | 9.9% | 0.83 | 4.3% | +39.9% | 0.00% |
| AGARWALEYE Dr. Agarwal's Health Care Limited | 17,535 cr | 102.4x | 7.8x | 8.3% | 15.2% | 0.09 | 8.7% | +31.4% | 0.00% |
| RAINBOW Rainbow Childrens Medicare Limited | 12,602 cr | 43.1x | 7.3x | 17.9% | 27.8% | 0.00 | 15.5% | +23.2% | 0.28% |
| YATHARTH Yatharth Hospital & Trauma Care Services Limited | 10,392 cr | 54.5x | 5.5x | 9.9% | 12.4% | 0.24 | 12.2% | +54.4% | 0.05% |
| PARKHOSPS Park Medi World Limited | 10,240 cr | 36.8x | 4.7x | 13.0% | 17.7% | 0.20 | 14.7% | - | 0.00% |
| JLHL Jupiter Life Line Hospitals Limited | 9,219 cr | 49.3x | 5.7x | 13.7% | 16.0% | 0.36 | 11.4% | +16.0% | 0.07% |
| HCG Healthcare Global Enterprises Limited | 9,181 cr | 866.1x | 6.8x | 1.9% | 9.4% | 0.52 | 0.8% | +13.1% | 0.00% |
| ARTEMISMED Artemis Medicare Services Limited | 5,370 cr | 46.8x | 5.4x | 11.6% | 14.8% | 0.24 | 10.0% | +13.2% | 0.13% |
| INDRAMEDCO Indraprastha Medical Corporation Limited | 3,303 cr | 17.2x | 4.1x | 27.5% | 37.7% | 0.00 | 12.3% | +8.3% | 1.11% |
| KMCSHIL K M C Speciality Hospitals (India) Limited | 3,288 cr | 53.8x | - | - | - | - | 17.5% | +24.1% | 0.00% |
| DRAGARWQ Dr Agarwals Eye Hospital Limited | 2,819 cr | 37.0x | - | - | - | - | 15.3% | +22.3% | 0.07% |
| SHALBY Shalby Limited | 1,317 cr | 34.3x | 1.3x | 3.5% | 6.7% | 0.53 | 3.2% | +9.7% | 0.00% |
| GKSL Gujarat Kidney And Super Speciality Limited | 1,187 cr | 55.1x | 4.5x | 6.6% | 8.6% | 0.06 | 16.2% | +194.6% | 0.00% |
| GPTHEALTH GPT Healthcare Limited | 1,087 cr | 20.9x | 3.8x | 16.3% | 23.1% | 0.05 | 10.2% | +14.1% | 0.76% |
| UNIHEALTH Unihealth Hospitals Limited | 774 cr | - | 7.5x | - | 16.2% | 0.13 | - | - | 0.00% |
| MOMSBELIEF Rays of Belief Limited | 573 cr | - | 3.8x | - | - | 0.15 | - | - | 0.00% |
| LOTUSEYE Lotus Eye Hospital and Institute Limited | 213 cr | 444.6x | 3.5x | 0.1% | 1.2% | 0.29 | 0.8% | +35.9% | 0.00% |
| NEPHROCARE Nephro Care India Limited | 149 cr | - | 2.4x | - | 8.7% | 0.00 | - | - | 0.00% |
| MAITREYA Maitreya Medicare Limited | 78 cr | - | 2.8x | - | -2.2% | 0.85 | -7.5% | -0.1% | 0.00% |
| SANGANI Sangani Hospitals Limited | 76 cr | 22.0x | 1.9x | - | 19.6% | 0.00 | 8.7% | -44.9% | 0.00% |
| AATMAJ Aatmaj Healthcare Limited | 58 cr | 102.8x | 1.1x | - | 3.6% | 0.45 | 1.9% | +56.9% | 0.00% |
| ABH ABH Healthcare Limited | 44 cr | - | 0.9x | - | - | 0.80 | - | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Month by month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.8 | +23.4 | -16.6 | +7.3 | +13.8 | +7.3 | -1.2 | -6.1 | -1.2 | -6.0 | +9.4 | · | +26.1% 11m |
| 2025 | +1.9 | -14.5 | +22.8 | +2.7 | +4.2 | -1.6 | +11.5 | -3.6 | -3.3 | +3.0 | -5.0 | -11.2 | +1.8% |
| 2024 | +7.9 | +5.7 | -8.8 | -1.3 | -10.2 | +14.1 | +3.0 | +17.9 | +9.9 | -2.1 | +8.2 | +1.4 | +51.1% |
| 2023 | -2.6 | -10.8 | +4.3 | +7.8 | +7.4 | +10.2 | +7.1 | +4.4 | -1.1 | -4.5 | +3.6 | +1.2 | +27.9% |
| 2022 | -5.5 | -5.9 | +9.1 | -3.1 | -2.1 | -9.7 | +4.8 | -3.1 | +25.8 | -1.9 | +0.8 | +3.3 | +8.5% |
| 2021 | · | · | · | · | · | · | +27.3 | +6.6 | -5.0 | -8.7 | +11.2 | +14.9 | +50.5% 6m |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2025-09-05 | GOLDMAN SACHS BANK EUROPE SE - ODI · block | BUY | 2,45,154 | ₹738.10 | ₹18.09 Cr |
| 2025-09-05 | GOLDMAN SACHS (SINGAPORE) PTE - ODI · block | SELL | 2,45,154 | ₹738.10 | ₹18.09 Cr |
| 2025-09-02 | GOLDMAN SACHS BANK EUROPE SE - ODI · block | BUY | 5,01,458 | ₹727.50 | ₹36.48 Cr |
| 2025-09-02 | GOLDMAN SACHS (SINGAPORE) PTE - ODI · block | SELL | 5,01,458 | ₹727.50 | ₹36.48 Cr |
| 2025-08-29 | GOLDMAN SACHS BANK EUROPE SE - ODI · block | BUY | 2,51,598 | ₹737.40 | ₹18.55 Cr |
| 2025-08-29 | GOLDMAN SACHS (SINGAPORE) PTE - ODI · block | SELL | 2,51,598 | ₹737.40 | ₹18.55 Cr |
| 2024-08-28 | INFINITY PARTNERS · bulk | BUY | 15,70,000 | ₹2,497.00 | ₹392.03 Cr |
| 2024-08-28 | INFINITY PARTNERS · block | BUY | 15,70,000 | ₹2,497.00 | ₹392.03 Cr |
- Board outcomeOutcome of Board Meeting4 Nov 2026
Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Board outcomeOutcome of Board Meeting3 Aug 2026
Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
- Board outcomeOutcome of Board Meeting15 May 2026
Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Board outcomeOutcome of Board Meeting15 May 2026
Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Board outcomeOutcome of Board Meeting6 Feb 2026
Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
- Board outcomeOutcome of Board Meeting7 Nov 2025
Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
- Board outcomeOutcome of Board Meeting6 Aug 2025
Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
- Press releasePress Release12 May 2025
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding a press release dated May 12, 2025, titled "Press Release on the audited (Standalone & Consolidated) financial results of the Companyfor the quarter and financial year ended 31st March 2025.".
- Press releasePress Release6 Feb 2025
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding a press release dated February 06, 2025, titled "Please find enclosed herewith the Press Release on the unaudited (Standalone & Consolidated) financial results of the Company for the 03rd quarter and nine months ended...
- Integrated Filing- Financial6 Feb 2025
We are submitting herewith the Integrated Filing (Financial) for the 3rd quarter and nine months ended December 31, 2024.
- Financial Result Updates6 Feb 2025
Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test KIMS. “Buy KIMS when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free